18 Nov 2026, 17:09
Director Interests—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 18 Nov 2026, 17:09 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 17 Nov 2026, 20:03 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 17 Nov 2026, 19:57 | Notification regarding unquoted securities - NTI | Securities Administration | — | 06021 | |
| 17 Nov 2026, 19:46 | Notification regarding unquoted securities - NTI | Securities Administration | — | 06021 | |
| 17 Nov 2026, 19:34 | Application for quotation of securities - NTI | Securities Administration | — | 06020 | |
| 11 Nov 2026, 13:37 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 6 Nov 2026, 15:03 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 5 Nov 2026, 11:39 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 28 Oct 2026, 08:22 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 20 Oct 2026, 09:55 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 20 Oct 2026, 09:50 | Corporate Presentation | Presentations | — | 03026 | |
| 19 Oct 2026, 18:38 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 7 Oct 2026, 10:51 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 5 Oct 2026, 17:41 | Annual Report (Typeset) | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 1 Oct 2026, 17:19 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 21 Sept 2026, 08:51 | NTI Doses First Patient in Phase 3 Beyond Harmony ASD Study | Company Update | MS | 11001 | |
| 8 Sept 2026, 19:24 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 8 Sept 2026, 16:46 | Notification of cessation of securities - NTI | Securities Administration | — | 06027 | |
| 8 Sept 2026, 09:49 | Board and Management Changes | Company Administration | — | 12001, 12017 | |
| 8 Sept 2026, 09:48 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 26 Aug 2026, 17:23 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 26 Aug 2026, 17:19 | Appendix 4E & Annual Report to shareholders | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 17 Aug 2026, 09:33 | Appointment of Executive Chairman | Company Administration | — | 12017 | |
| 13 Aug 2026, 13:39 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 11 Aug 2026, 18:01 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 11 Aug 2026, 17:58 | Application for quotation of securities - NTI | Securities Administration | — | 06020 | |
| 4 Aug 2026, 09:27 | Proposed issue of securities - NTI | Securities Administration | — | 06013 | |
| 4 Aug 2026, 09:27 | Proposed issue of securities - NTI | Securities Administration | — | 06013 | |
| 4 Aug 2026, 09:26 | Receipt of Binding Commitments for $4.5m Placement | Capital Raising | MS | 06003, 09014 | |
| 31 July 2026, 10:59 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 31 July 2026, 09:22 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 30 July 2026, 09:00 | NTI164 Phase II/III Autism Data Accepted for Publication | Company Update | — | 11001 | |
| 21 July 2026, 16:43 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 21 July 2026, 16:37 | Application for quotation of securities - NTI | Securities Administration | — | 06020 | |
| 15 July 2026, 12:11 | Neurotech secures $3.15 million R&D tax incentive loan | Periodic Reports | MS | 03014, 12008 | |
| 14 July 2026, 08:50 | US FDA clears IND for NTI164 | Company Update | MS | 11001 | |
| 13 July 2026, 19:16 | Notification regarding unquoted securities - NTI | Securities Administration | — | 06021 | |
| 13 July 2026, 09:32 | Proposed issue of securities - NTI | Securities Administration | — | 06013 | |
| 2 July 2026, 09:35 | NTI secures Notices of Allowance for US patent applications | Company Update | MS | 11001 | |
| 29 June 2026, 16:39 | Notification of cessation of securities - NTI | Securities Administration | — | 06027 | |
| 29 Apr 2026, 09:42 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 15:20 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 28 Apr 2026, 15:18 | Notification of cessation of securities - NTI | Securities Administration | — | 06027 | |
| 23 Apr 2026, 18:40 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 13 Apr 2026, 09:19 | Neurotech to present at Ignite Investment Summit Hong Kong | Presentations | — | 03026 | |
| 31 Mar 2026, 18:17 | Change of Director's Interest Notice x 4 | Director Interests | — | 02009 | |
| 30 Mar 2026, 18:44 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 30 Mar 2026, 18:37 | Application for quotation of securities - NTI | Securities Administration | — | 06020 | |
| 23 Mar 2026, 09:28 | Neurotech to present at NWR Virtual Healthcare Conference | Presentations | — | 14014 | |
| 18 Mar 2026, 09:33 | Corporate Presentation | Presentations | — | 03026 |